C
Cellivery Therapeutics Inc
KOSDAQ:268600
Cellivery Therapeutics Inc
KOSDAQ:268600
Price:
6 680
KRW
-29.91%
Market Cap:
₩594.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Cellivery Therapeutics Inc
KOSDAQ:268600
|
KR |
|
Zhongtai Securities Co Ltd
SSE:600918
|
CN |
|
C
|
CCS Supply Chain Management Co Ltd
SSE:600180
|
CN |
|
SASA Polyester Sanayi AS
IST:SASA.E
|
TR |
|
Guangdong Cellwise Microelectronics Co Ltd
SSE:688325
|
CN |
|
S
|
Sapura Resources Bhd
KLSE:SAPRES
|
MY |
|
S
|
Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252
|
CN |
|
Bilfinger SE
XETRA:GBF
|
DE |
|
P
|
Prosiebensat 1 Media SE
XETRA:PSM
|
DE |
|
CapitaLand Integrated Commercial Trust
SGX:C38U
|
SG |
|
Time Publishing and Media Co Ltd
SSE:600551
|
CN |
|
ADF Foods Ltd
NSE:ADFFOODS
|
IN |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of Cellivery Therapeutics Inc.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
Competitors Multiples
Cellivery Therapeutics Inc Competitors
Cellivery Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
C
|
Cellivery Therapeutics Inc
KOSDAQ:268600
|
594.9m KRW | 0 | -0.1 | -1.5 | -1.1 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
967B USD | 338.6 | 4 009 | 1 148.8 | 2 212.1 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
183.9B USD | 4.1 | 27.4 | 19.1 | 25.6 | |
| US |
|
Danaher Corp
NYSE:DHR
|
132.9B USD | 5.4 | 36.8 | 18.7 | 27.3 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.3B CHF | 5.2 | 36 | 26.8 | 26.8 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
271B CNY | 6.1 | 18.1 | 18.2 | 18.2 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.1B USD | 4.5 | 24.9 | 18.3 | 21.6 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.5B USD | 9.3 | 45.8 | 29.6 | 37.2 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.7B USD | 1.8 | 21.2 | 11.8 | 17.8 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.9B USD | 6.4 | 29.7 | 22.1 | 24.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
